Amoxibactin 250 mg tablets for dogs
Amoxibactin 250 mg tablets for dogs
Authorised
- Amoxicillin trihydrate
Product identification
Medicine name:
Amoxibactin 250 mg tablets for dogs
Amoxibactin Vet. 250 mg tabletter
Active substance:
- Amoxicillin trihydrate
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Amoxicillin trihydrate287.50milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01CA04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Denmark
Package description:
- Cardboard box of 9 Aluminium - PVC/PE/PVDC blisters of 10 tablets.
- Cardboard box of 8 Aluminium - PVC/PE/PVDC blisters of 10 tablets.
- Cardboard box of 7 Aluminium - PVC/PE/PVDC blisters of 10 tablets.
- Cardboard box of 6 Aluminium - PVC/PE/PVDC blisters of 10 tablets.
- Cardboard box of 3 Aluminium - PVC/PE/PVDC blisters of 10 tablets.
- Cardboard box of 25 Aluminium - PVC/PE/PVDC blisters of 10 tablets
- Cardboard box of 2 Aluminium - PVC/PE/PVDC blisters of 10 tablets.
- Cardboard box of 10 Aluminium - PVC/PE/PVDC blisters of 10 tablets
- Cardboard box of 1 Aluminium - PVC/PE/PVDC blister of 10 tablets.
- Cardboard box of 50 Aluminium - PVC/PE/PVDC blisters of 10 tablets
- Cardboard box of 5 Aluminium - PVC/PE/PVDC blisters of 10 tablets.
- Cardboard box of 4 Aluminium - PVC/PE/PVDC blisters of 10 tablets.
- Cardboard box containing 10 separate cardboard boxes, each containing 1 blister of 10 tablets
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Le Vet. Beheer B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Lelypharma B.V.
Responsible authority:
- Danish Health And Medicines Authority
Authorisation number:
- 53364
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0186/002
Concerned member states:
-
Austria
-
Belgium
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Norway
-
Poland
-
Portugal
-
Slovakia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Danish (, TABLETTER 250 MG OG 500 MG)
Published on: 29/06/2023
How useful was this page?: